Page last updated: 2024-10-31

neostigmine and Acute Lung Injury

neostigmine has been researched along with Acute Lung Injury in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kox, M1
Pompe, JC1
Peters, E1
Vaneker, M1
van der Laak, JW1
van der Hoeven, JG1
Scheffer, GJ1
Hoedemaekers, CW1
Pickkers, P1

Other Studies

1 other study available for neostigmine and Acute Lung Injury

ArticleYear
α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
    British journal of anaesthesia, 2011, Volume: 107, Issue:4

    Topics: Acute Lung Injury; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Cholines

2011